Recall urticaria induced by skin tests with heparin

Weber, Hans-Joachim; Fischer, Johan; Kneilling, Manfred; Caroli, Ulrich M.; Röcken, Michael; Biedermann, Tilo

doi:10.1111/j.1365-2133.2009.09150.x

Cited by 13 publications

(11 citation statements)

References 8 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Allergologic testig was performed almost 12 months after this episode. While absence of a reaction at the test site was noticed, she developed recall urticaria at former injection sites of dalteparin (72).…”

Section: Recall Urticaria To Heparinmentioning

confidence: 99%

“…As mast cells are crucial for immediate hypersensitivity reactions (36), they are the most obvious candidates for mediating this type of localized tissue memory. In total, two patients with recall urticaria to heparin have been described (16,72). A recently described 42-year-old woman was treated with dalteparin undergoing radioactive iodine therapy.…”

Section: Recall Urticaria To Heparinmentioning

confidence: 99%

See 1 more Smart Citation

Heparin-induced skin lesions

Schindewolf¹,

Kahle²,

Lindhoff-Last³

et al. 2010

Phlebologie

View full text Add to dashboard Cite

SummaryCutaneous reactions to subcutaneous heparin injections have been described first in 1952. These reactions may be caused by several mechanisms such as immediate or delayed-type hypersensitivity responses, or by life-threatening immune-mediated heparin-induced thrombocytopenia (HIT). In contrast to bleeding, induction of osteoporosis and hair loss, no data on the incidence and causes of heparin-induced skin lesions had been available until recently. In a large prospective epidemiological study, the incidence of heparin-induced skin lesions was as high as 7.5% in medical patients, far exceeding the expected incidence. As heparin-induced skin lesions may be the sole clinical manifestation of immune HIT, rapid and valid diagnosis of heparin-induced skin lesions is of utmost clinical importance. Therefore, we have reviewed all known causes of heparin-induced skin lesions, and propose diagnostic and therapeutic procedures.

show abstract

Section: Recall Urticaria To Heparinmentioning

confidence: 99%

Section: Recall Urticaria To Heparinmentioning

confidence: 99%

Heparin-induced skin lesions

Schindewolf¹,

Kahle²,

Lindhoff-Last³

et al. 2010

Phlebologie

View full text Add to dashboard Cite

show abstract

“…The most common example is that of patients who have previously received subcutaneous allergen immunotherapy (scAIT) and present focal skin reaction at the sites of previous allergen injections when a new allergen is administered or after marked environmental exposure to the allergen [1,2]. However, other stimuli such as foods [1] and drugs (eg, heparin [3,4] and levofloxacin [5]) have been involved.…”

mentioning

confidence: 99%

“…Mortality is 30%-35% for toxic epidermal necrolysis, 5%-15% for Stevens-Johnson syndrome, and 10% for drug rash with eosinophilia and systemic symptoms (DRESS) syndrome. Cross-reactivity between sulfonamide drugs is controversial [3,4].…”

mentioning

confidence: 99%

Recall Urticaria: Aspirin Also Induces It

Cimbollek

Labella

et al. 2018

J Investig Allergol Clin Immunol

View full text Add to dashboard Cite

“…2 Its aetiology and pathogenesis are yet to be fully understood and significant efforts have been directed towards elucidation of the underlying mechanisms as well as improvement of optimal management of these patients. [3][4][5][6][7][8][9][10][11][12][13][14][15][16][17] Despite recent publication of guidelines from the British Association of Dermatologists as well as the joint guidelines of the European Academy of Allergology and Clinical Immunology, EU-funded network of excellence, Global Allergy and Asthma European Network, European Dermatology Forum, Urticaria Network and World Allergy Organization, there are surprisingly few evidencebased recommendations currently available to medical practitioners and thus this meeting was organized to summarize such evidence and also to draw on the experience of international experts in this area. 1,[18][19][20] To set the scene, Dr Stuart Cohen (Nottingham, U.K.) updated the audience on the progress of a systematic Cochrane review of antihistamines use for chronic ordinary (spontaneous) urticaria (CSU).…”

mentioning

confidence: 99%

Urticaria: an evidence-based update. Conference report

Alexandroff

Harman

2010

British Journal of Dermatology

View full text Add to dashboard Cite

Summary Evidence-based update meetings are held annually by the Centre of Evidence Based Dermatology, University of Nottingham. Topics are chosen by delegates at the previous year's conference and in the past have included blistering disorders, psoriasis, hair disorders and skin cancers. Once the topic is identified, a trials database search is undertaken with the aim of including speakers who are actively involved in trials that address the subject in question. This year, the eighth Evidence Based Update meeting focused on urticaria and took place in Loughborough University on 14 May 2009. The latest data on the diagnosis and management of acute and chronic urticaria, including cold and solar urticaria, and the impact of food intolerance on chronic urticaria, were presented by an international panel of renowned speakers, who sometimes expressed different viewpoints. The highlights of the meeting included an informal atmosphere, an international perspective, and a practical question and answer session. Over 70% of the delegates stated that they would be changing their clinical practice following on from the meeting. The evidence-based update meeting in 2010 will be devoted to eczema.

show abstract

Recall urticaria induced by skin tests with heparin

Cited by 13 publications

References 8 publications

Heparin-induced skin lesions

Heparin-induced skin lesions

Recall Urticaria: Aspirin Also Induces It

Urticaria: an evidence-based update. Conference report

Contact Info

Product

Resources

About